drugset / Trial / NCT00002369

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002369

Completed 200 enrolled Bristol-Myers Squibb
Parallel-groupTreatment

Summary

To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Stavudine Other / unclassified
Subject Zidovudine Small molecule
Background INDINAVIR ANHYDROUS Other / unclassified
Background Lamivudine Other / unclassified